We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multi-electrode Radiofrequency Renal Denervation System Feasibility Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01699529
First Posted: October 3, 2012
Last Update Posted: October 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Medtronic Vascular
  Purpose
This is a prospective, single-arm, non-randomized and open label feasibility study. The study is intended to evaluate safety and efficacy of multi-electrode radiofrequency renal denervation in patients with uncontrolled hypertension.

Condition Intervention
Uncontrolled Hypertension Device: Medtronic Multi-electrode Radiofrequency (RF) Renal Denervation system

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Multi-electrode Radiofrequency Renal Denervation System Feasibility Study

Further study details as provided by Medtronic Vascular:

Primary Outcome Measures:
  • Acute safety as measured by procedural complications [ Time Frame: 1 month ]

Secondary Outcome Measures:
  • Change in Office Systolic Blood Pressure [ Time Frame: Baseline to 6 months ]

Enrollment: 50
Study Start Date: September 2012
Study Completion Date: October 2016
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Renal Denervation Device: Medtronic Multi-electrode Radiofrequency (RF) Renal Denervation system
The Medtronic Multi-electrode Radiofrequency Renal Denervation System is comprised of a single-use, disposable catheter and a reusable generator.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individual is ≥ 18 and ≤ 80 years old.
  • Individual has an office systolic blood pressure of 160 mmHG or greater (≥ 150 mmHg for Type 2 diabetics) based on an average of 3 office/clinic blood pressure readings
  • Individual is adhering to a stable medication regimen including ≥ 3 anti-hypertensive medications(preferred that one is a diuretic) for a minimum of two weeks prior to screening.

Exclusion Criteria:

  • Individual has an estimated glomerular filtration rate (eGFR) of < 45 mL/min/1.73 m2
  • Individual has type 1 diabetes mellitus
  • Individual requires chronic oxygen support or mechanical ventilation (e.g., tracheostomy, CPAP, BiPAP) other than nocturnal respiratory support for sleep apnea.
  • Individual has primary pulmonary hypertension.
  • Individual is pregnant, nursing or planning to be pregnant.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01699529


Locations
Australia, Victoria
Alfred Hospital
Melbourne, Victoria, Australia, 3004
St. Vincent's Hospital Melbourne
Melbourne, Victoria, Australia, 3065
Epworth Hospital
Melbourne, Victoria, Australia, 3069
New Zealand
Wellington Hospital
Wellington, New Zealand
Sponsors and Collaborators
Medtronic Vascular
Investigators
Principal Investigator: Robert Whitbourn, MD St Vincent's Hospital Melbourne
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Medtronic Vascular
ClinicalTrials.gov Identifier: NCT01699529     History of Changes
Other Study ID Numbers: 10058715DOC
First Submitted: September 21, 2012
First Posted: October 3, 2012
Last Update Posted: October 26, 2016
Last Verified: October 2016

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases